New drug could help alopecia patients grow hair
A drug approved for treating a bone marrow disorder could be effective in helping alopecia sufferers regrow hair.
Researchers at Columbia University Medical Center tested the drug on sufferers of alopecia areata, a disease that causes body-wide hair loss and affects roughly 1 percent of men and women.
The research team at Columbia first tested the new drug class, JAK inhibitors, on mice. When the mouse experiment was successful, the researchers tested one of the drugs, ruxolitinib, on five men and seven women. Some of the study's findings were published Sunday in the Nature Medicine journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Most of the participants experienced significant hair growth over time, while a few others' hair did not regrow. "It appears to work — not in everyone, but in the majority," Dr. Julian Mackay-Wiggan, director of Columbia's dermatology clinical research unit and an author of the study, told The New York Times. "We need a lot more data on the long-term risks in healthy individuals. But it's certainly very exciting in terms of hair growth. It was surprising how quickly and impressively the growth occurred."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
-
Gaetz bows out, Trump pivots to Pam Bondi
Speed Read Gaetz withdrew from attorney generation consideration, making way for longtime Trump loyalist Pam Bondi
By Rafi Schwartz, The Week US Published
-
'The double standards don't trouble the critics'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Today's political cartoons - November 22, 2024
Cartoons Friday's cartoons - frozen assets, blazing fires, and more
By The Week US Published
-
DOJ demands changes at 'abhorrent' Atlanta jail
Speed Read Georgia's Fulton County Jail subjects inmates to 'unconstitutional' conditions, the 16-month investigation found
By Rafi Schwartz, The Week US Published
-
China tries to bury deadly car attack
Speed Read An SUV drove into a crowd of people in Zhuhai, killing and injuring dozens — but news of the attack has been censored
By Peter Weber, The Week US Published
-
Menendez brothers may go free in LA prosecutor plan
Speed Read Prosecutors are asking for the brothers to be resentenced for the 1989 murder of their parents
By Peter Weber, The Week US Published
-
Abercrombie ex-CEO charged with sex crimes
Speed Read Mike Jeffries ran the brand during its heyday from 1992 to 2014
By Rafi Schwartz, The Week US Published
-
Trump criminal trial starts with rulings, reminder
Speed Read The first day of his historic trial over hush money payments was mostly focused on jury selection
By Rafi Schwartz, The Week US Published
-
Parents of school shooter sentenced to 10-15 years
Speed Read Jennifer and James Crumbley are the first parents to be convicted in a US mass shooting
By Peter Weber, The Week US Published
-
Unlicensed dealers and black market guns
Speed Read 68,000 illegally trafficked guns were sold in a five year period, said ATF
By Peter Weber, The Week US Published
-
Bankman-Fried gets 25 years for fraud
Speed Read Former "crypto king" Sam Bankman-Fried will report to federal prison
By Peter Weber, The Week US Published